SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

OK Biotech Reports October Revenue of NT$153.3M

OK Biotech reported October revenue of NT$153,281,000, compared with NT$128,199,000 a year earlier. January–October revenue was NT$1,543,135,000 versus NT$1,347,943,000 in 2025.

4155
SquawkNews Desk

OK Biotech Co. Ltd. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$153,281,000 NT$128,199,000 Jan-Oct Revenue NT$1,543,135,000 NT$1,347,943,000 Source: Taiwan Stock Exchange This content was…

Related stories

MRF Q2 Continuing-Operations Profit 3.69 Billion Rupees M impact | EQUITY | Nov 10, 2026, 07:09 AM UTC Pelagic Credit Signs US$30 Million Financing Agreement for Two Suezmax Tankers Pelagic Credit Plc said it signed a US$30 million mezzanine financing agreement for two Suezmax tankers. M impact | EQUITY | Nov 10, 2026, 07:03 AM UTC Apple Team Visits Tata India iPhone Factory After Worker Deaths Apple's team is visiting Tata's iPhone components factory in India to investigate worker deaths. M impact | EQUITY | Nov 10, 2026, 07:03 AM UTC TSM Shares Rise 1% Overnight Ahead of Tuesday Taiwan Semiconductor Manufacturing shares rose 1% in overnight trading. The report cites a sharp increase in monthly sales and says gains were tempered by controversy involving Nvi M impact | EQUITY | Nov 10, 2026, 07:02 AM UTC Asian session market picture: S&P 500 +0.2%, Nasdaq 100 -0.12%; USD/JPY +0.07%, WTI -1.8%, 1810 leads volume Asian session market picture. US index futures: S and P futures is up 0.2 percent, Nasdaq futures is down 0.12 percent, Dow futures is up 0.43 percent and Russell futures is up 0.2 M impact | EQUITY | Nov 10, 2026, 07:02 AM UTC Universal Cement Reports October Revenue of NT$641.8 Million Universal Cement reported October revenue of NT$641.843 million, versus NT$723.076 million a year earlier. January–October revenue was NT$5,998.028 million, compared with NT$6,506. M impact | EQUITY | Nov 10, 2026, 06:59 AM UTC